1
Masclee, G.M., Penders, J., Jonkers, D.M.A.E., Wolffs, P.F.G., Pierik, M.J.
Veröffentlicht in: Masclee , G M , Penders , J , Jonkers , D M A E , Wolffs , P F G & Pierik , M J 2013 , ' Is clostridium difficile associated with relapse of inflammatory bowel disease? results from a retrospective and prospective cohort study in the Netherlands ' , Inflammatory Bowel Diseases , vol. 19 , no. 10 , pp. 2125-2131 . https://doi.org/10.1097/MIB.0b013e318297d222;
2013
Veröffentlicht in: Masclee , G M , Penders , J , Jonkers , D M A E , Wolffs , P F G & Pierik , M J 2013 , ' Is clostridium difficile associated with relapse of inflammatory bowel disease? results from a retrospective and prospective cohort study in the Netherlands ' , Inflammatory Bowel Diseases , vol. 19 , no. 10 , pp. 2125-2131 . https://doi.org/10.1097/MIB.0b013e318297d222;
2013
2
3
Spekhorst, LM, Oldenburg, B, van Bodegraven, AA, de Jong, DJ, Imhann, F, de Jong, AE, Pierik, MJ, van der Woude, C.J., Dijkstra, G, D'Haens, G, Lowenberg, M, Weersma, RK, Festen, EAM
Veröffentlicht in: Spekhorst , LM , Oldenburg , B , van Bodegraven , AA , de Jong , DJ , Imhann , F , de Jong , AE , Pierik , MJ , van der Woude , C J , Dijkstra , G , D'Haens , G , Lowenberg , M , Weersma , RK & Festen , EAM 2017 , ' Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease ' , World Journal of Gastroenterology , vol. 23 , no. 46 , pp. 8182-8192 . https://doi.org/10.3748/wjg.v23.i46.8182;
2017
Veröffentlicht in: Spekhorst , LM , Oldenburg , B , van Bodegraven , AA , de Jong , DJ , Imhann , F , de Jong , AE , Pierik , MJ , van der Woude , C J , Dijkstra , G , D'Haens , G , Lowenberg , M , Weersma , RK & Festen , EAM 2017 , ' Prevalence of- and risk factors for work disability in Dutch patients with inflammatory bowel disease ' , World Journal of Gastroenterology , vol. 23 , no. 46 , pp. 8182-8192 . https://doi.org/10.3748/wjg.v23.i46.8182;
2017
4
Jeuring, S.F.G., Bours, P.H.A., Zeegers, M.P., Ambergen, T.W., van den Heuvel, T.R.A., Romberg-Camps, M.J.L., van Bodegraven, A.A., Oostenburg, L.E., Breukink, S.O., Stassen, L.P.S., Hameeteman, W.H., Masclee, A.A.M., Jonkers, D.M.A.E., Pierik, M.J.
Veröffentlicht in: Jeuring , S F G , Bours , P H A , Zeegers , M P , Ambergen , T W , van den Heuvel , T R A , Romberg-Camps , M J L , van Bodegraven , A A , Oostenburg , L E , Breukink , S O , Stassen , L P S , Hameeteman , W H , Masclee , A A M , Jonkers , D M A E & Pierik , M J 2015 , ' Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-based IBDSL Cohort ' , Journal of Crohn's & Colitis , vol. 9 , no. 10 , pp. 837-845 . https://doi.org/10.1093/ecco-jcc/jjv129;
2015
Veröffentlicht in: Jeuring , S F G , Bours , P H A , Zeegers , M P , Ambergen , T W , van den Heuvel , T R A , Romberg-Camps , M J L , van Bodegraven , A A , Oostenburg , L E , Breukink , S O , Stassen , L P S , Hameeteman , W H , Masclee , A A M , Jonkers , D M A E & Pierik , M J 2015 , ' Disease Outcome of Ulcerative Colitis in an Era of Changing Treatment Strategies: Results from the Dutch Population-based IBDSL Cohort ' , Journal of Crohn's & Colitis , vol. 9 , no. 10 , pp. 837-845 . https://doi.org/10.1093/ecco-jcc/jjv129;
2015
5
Biemans, VBC, Sleutjes, Jasmijn, de Vries, Annemarie, Bodelier, AG, Dijkstra, A, Oldenburg, B, Löwenberg, M, van Bodegraven, AA, de Jong, AEE, de Boer, NK, Srivastava, N, West, RL, Römkens, TEH, Horjus Talabur Horje, CS, Jansen, J, van der Woude, C.J., Hoekstra, J, Weersma, RK, van Schaik, FDM, Hoentjen, F, Pierik, MJ
Veröffentlicht in: Biemans , VBC , Sleutjes , J , de Vries , A , Bodelier , AG , Dijkstra , A , Oldenburg , B , Löwenberg , M , van Bodegraven , AA , de Jong , AEE , de Boer , NK , Srivastava , N , West , RL , Römkens , TEH , Horjus Talabur Horje , CS , Jansen , J , van der Woude , C J , Hoekstra , J , Weersma , RK , van Schaik , FDM , Hoentjen , F & Pierik , MJ 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020
Veröffentlicht in: Biemans , VBC , Sleutjes , J , de Vries , A , Bodelier , AG , Dijkstra , A , Oldenburg , B , Löwenberg , M , van Bodegraven , AA , de Jong , AEE , de Boer , NK , Srivastava , N , West , RL , Römkens , TEH , Horjus Talabur Horje , CS , Jansen , J , van der Woude , C J , Hoekstra , J , Weersma , RK , van Schaik , FDM , Hoentjen , F & Pierik , MJ 2020 , ' Tofacitinib for ulcerative colitis: results of the prospective Dutch Initiative on Crohn and Colitis (ICC) registry ' , Alimentary Pharmacology and Therapeutics , vol. 51 , no. 9 , pp. 880-888 . https://doi.org/10.1111/apt.15689;
2020